Abstract:Background Autoinflammatory diseases are inherited disorders of the innate immune system caused by aberrant activation of the innate immune cells, primarily neutrophils and macrophages. Genetic studies have led to the identification of mutations in 12 genes responsible for various monogenic autoinflammatory diseases, however a significant number of mutation negative patients are sporadic cases or come from small families underpowered for linkage analysis. Objectives To identify disease causing mutation in a family with dominantly inherited inflammatory disease characterized by recurrent blistering skin lesions, pulmonary disease, arthralgia, inflammatory eye, bowel disease, absence of autoantibodies, and mild immunodeficiency manifested by recurrent sino-pulmonary infections. Methods Whole-exome sequencing was performed on three samples, including the affected father and daughter and unaffected mother. Exome data were filtered in more than 6000 exomes to exclude reported variants along with benign variants as determined by PolyPhen-2. A total of eight transcripts were identified as possible candidate genes. Results We confirmed a novel variant, p. S707Y, within the PLCG2 gene as the only de novo variant that was present in two affected and not present in four unaffected family members. PLCG2 encodes phospholipase Cγ2 (PLCγ2), an enzyme with a critical regulatory role in various immune and inflammatory pathways. The S707Y mutation is located in an autoinhibitory SH2 domain that is crucial for PLCγ2 activation. In vitro overexpression of the mutant S707Y protein and ex vivo experiments using patients’ leucocytes showed clearly enhanced PLCγ2 activity suggesting an increased intracellular signaling in the PLCγ2-mediated signaling pathway. Our finding that p. S707Y is hypermorphic mutation in PLCγ2 is further corroborated by animal studies that have implicated the critical role for PLCg2 in regulation of inflammation in mice. Two missense gain-of-function mutations in the murine phospholipase Cg2 (Plcg2) gene introduced by ENU mutagenesis, ALI5 and ALI14, lead to severe spontaneous inflammation and autoimmunity. Conclusions Recently, PLCG2 exon skipping mutations were reported in PLAID patients who present with cold-induced urticaria and immune dysregulation resulting in protein products with constitutive phospholipase activity but with reduced intracellular signaling at physiological temperature (ref). In contrast, we report here a missense PLCG2 mutation as a cause of a distinct inflammatory disease not provoked by cold temperatures, with different end-organ involvement and different cellular phenotype. Our result highlights the utility of exome sequencing technology in finding causal genes in nuclear families with dominantly inherited traits otherwise intractable by linkage analysis. References Ombrello, M.J., Remmers, E.F., Sun, G., Freeman, A.F., Datta, S., Torabi-Parizi, P., Subramanian, N., Bunney, T.D., Baxendale, R.W., Martins, M.S., et al. Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions. N Engl J Med. Disclosure of Interest None Declared

A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant

CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease

Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease

Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy

Novel CARMIL2 (RLTPR) Mutation Presenting with Hyper-IgE and Eosinophilia: A Case Report

Evolution and long‐term outcomes of combined immunodeficiency due to CARMIL2 deficiency

Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency

Profound immunodeficiency with severe skin disease explained by concomitant novel CARMIL2 and PLEC1 loss-of-function mutations

A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction

Case Report: A novel IRF2BP2 mutation in an IEI patient with recurrent infections and autoimmune disorders

Infantile Inflammatory Bowel Disease-Like Colitis Caused by IL2RG Gene Mutation: A Case Report and Literature Review

CARMIL2 Immunodeficiency with Epstein Barr Virus Associated Smooth Muscle Tumor (EBV-SMT). Report of a Case with Comprehensive Review of Literature

Variants in TRIM22 That Affect NOD2 Signaling Are Associated with Very-Early-Onset Inflammatory Bowel Disease.

OP0174 Exome Sequencing Identifies a Hypermorphic Missense Mutation in the PLCG2 Gene As the Cause of a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency

Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant

Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants

A Hypermorphic Missense Mutation in PLCG2, Encoding Phospholipase Cγ2, Causes a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency.

Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study

Analysis of a child with Very early onset inflammatory bowel disease due to compound heterozygous variants of IL10RA and DUOX2 genes

A human immunodeficiency syndrome caused by mutations in CARMIL2